文献速递脑血管病外科神经重症

特发性颅内高压:硬脑膜静脉窦支架置入后120天临床、影像学及测压结果

Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus.
PubMed 文献 · J Neurosurg · 2017-10-06

本研究为单中心病例系列,回顾41例特发性颅内高压患者硬脑膜静脉窦支架置入前后临床、影像及测压资料;术后3-4个月静脉窦压力较术前降低11-15 mmHg,并发症率4.9%,120天支架通畅率87.8%,但至少20%患者发生再狭窄,仅63.3%视乳头水肿改善或消退。

要点

  • 支架术后3-4个月静脉窦压力较术前降低11-15 mmHg。
  • 支架术后并发症率4.9%,120天支架存活率87.8%。
  • 至少20%患者发生再狭窄,仅63.3%视乳头水肿改善或消退。

核心结论

  • 术后120天观察到静脉窦压力降低。
  • 硬脑膜静脉窦支架的并发症率低于分流术,但临床结局数据不够令人信服。
  • 要明确比较硬脑膜静脉窦支架与分流术在特发性颅内高压中的结局,需要随机前瞻性研究。

研究设计与样本

  • 单中心病例系列,回顾分析41例特发性颅内高压患者硬脑膜静脉窦支架置入前后的临床、影像和测压资料。
  • 所有静脉造影和测压操作均在局部麻醉、患者仰卧位下进行。

主要发现

  • 无论手术是初次还是继发(分流术后),术后3-4个月静脉窦压力较支架前基线降低11-15 mmHg。
  • 观察到与压力梯度降低相关的解剖性狭窄影像学消除。
  • 支架术后并发症率为4.9%,120天支架存活率为87.8%。
  • 至少20%的患者在硬脑膜静脉窦支架后发生再狭窄,仅63.3%的患者视乳头水肿改善或消退。

临床怎么用

  • 作者认为硬脑膜静脉窦支架的并发症率低于分流术,但临床结局数据不够令人信服。
  • 作者提出需要随机前瞻性研究来明确比较硬脑膜静脉窦支架与分流术的结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Idiopathic intracranial hypertension (IIH) is commonly associated with venous sinus stenosis. In recent years, transvenous dural venous sinus stent (DVSS) insertion has emerged as a potential therapy for resistant cases. However, there remains considerable uncertainty over the safety and efficacy of this procedure, in particular the incidence of intraprocedural and delayed complications and in the longevity of sinus patency, pressure gradient obliteration, and therapeutic clinical outcome. The aim of this study was to determine clinical, radiological, and manometric outcomes at 3-4 months after DVSS in this treated IIH cohort. METHODS Clinical, radiographic, and manometric data before and 3-4 months after DVSS were reviewed in this single-center case series. All venographic and manometric procedures were performed under local anesthesia with the patient supine. RESULTS Forty-one patients underwent DVSS venography/manometry within 120 days. Sinus pressure reduction of between 11 and 15 mm Hg was achieved 3-4 months after DVSS compared with pre-stent baseline, regardless of whether the procedure was primary or secondary (after shunt surgery). Radiographic obliteration of anatomical stenosis correlating with reduction in pressure gradients was observed. The complication rate after DVSS was 4.9% and stent survival was 87.8% at 120 days. At least 20% of patients developed restenosis following DVSS and only 63.3% demonstrated an improvement or resolution of papilledema. CONCLUSIONS Reduced venous sinus pressures were observed at 120 days after the procedure. DVSS showed lower complication rates than shunts, but the clinical outcome data were less convincing. To definitively compare the outcomes between DVSS and shunts in IIH, a randomized prospective study is needed.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Asif H, Craven CL, Siddiqui AH, et al. Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus. J Neurosurg. 2017. PMID: 28984521. doi:10.3171/2017.4.JNS162871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。